These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33969701)

  • 1. Impact of Renin-Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery.
    Antoniak DT; Walters RW; Alla VM
    J Am Heart Assoc; 2021 May; 10(10):e019731. PubMed ID: 33969701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.
    Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.
    Manning MW; Cooter M; Mathew J; Alexander J; Peterson E; Ferguson TB; Lopes R; Podgoreanu M
    Ann Thorac Surg; 2017 Jul; 104(1):98-105. PubMed ID: 28131423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury.
    Kim KA; Lee JE; Choi IJ; Lee KY; Kim CJ; Park MW; Park CS; Kim HY; Yoo KD; Jeon DS; Jeong MH; Chang K
    Cardiorenal Med; 2024; 14(1):178-190. PubMed ID: 38471483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome.
    Li XY; Sun JF; Hu SQ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1375-1383. PubMed ID: 28387887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
    J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program.
    Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan.
    Tsuchimoto A; Masutani K; Ueki K; Nakagawa K; Matsukuma Y; Tanaka S; Unagami K; Kakuta Y; Okumi M; Noguchi H; Kaku K; Okabe Y; Nakano T; Kitazono T; Nakamura M; Ishida H; Tanabe K;
    Clin Exp Nephrol; 2020 Apr; 24(4):369-378. PubMed ID: 31875930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction.
    Darden D; Drazner MH; Mullens W; Dupont M; Tang WHW; Grodin JL
    Clin Cardiol; 2019 Oct; 42(10):1010-1018. PubMed ID: 31498919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial.
    van Diepen S; Norris CM; Zheng Y; Nagendran J; Graham MM; Gaete Ortega D; Townsend DR; Ezekowitz JA; Bagshaw SM
    J Am Heart Assoc; 2018 Oct; 7(20):e009917. PubMed ID: 30371293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
    Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
    Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting.
    Kim J; Park J; Lee JH; Min JJ; Lee SH; Lee YT; Kim WS; Song S; Yeo JH; Cho H
    Sci Rep; 2020 Feb; 10(1):1716. PubMed ID: 32015422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
    BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative use of renin-angiotensin system inhibitors and outcomes in patients undergoing cardiac surgery.
    Ding Q; Zhang Z; Liu H; Nie H; Berguson M; Goldhammer JE; Young N; Boyd D; Morris R; Sun J
    Nat Commun; 2019 Sep; 10(1):4202. PubMed ID: 31519895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.